Key information here to guess
1 Independent draft report outcome
This report has incurred Pfizer to react immediately, likely RAP valued more than 11.5C, otherwise the scheme vote will stay on track
2 The company considers the draft
The more indifferent BOD shows, the more it reveals the conflict they are facing. They were asked to support the schemes before the voting, looks like that job is now finished, and they are not sure what to do next.
3 Pfizer decision
If the valuation is below or close to 20c, it is not reasonable that Pfizer leave the game they started given their input, here they may raise the T/O. As the company said they are considering the draft, my guess is either Pfizer stopped the offer for some reason or changed to offer which request BOD step down
all imo
- Forums
- ASX - By Stock
- RAP
- Ann: Trading Halt
Ann: Trading Halt, page-23
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online